A Study to Investigate the Safety, Tolerability and Drug Behavior of Inhaled AZD4604 and to Investigate the Anti-inflammatory Effect of AZD4604

Condition:   Asthma Interventions:   Drug: AZD4604 for inhalation via nebulizer;   Drug: Placebo for AZD4604 for inhalation via nebulizer;   Drug: AZD4604 for inhalation via DPI;   Drug: Placebo for AZD4604 for inhalation via DPI;   Drug: AZD4604 for IV administration;   Drug: AZD4604 for oral administ ration Sponsor:   AstraZeneca Not yet recruiting

Source: ClinicalTrials.gov - February 25, 2021 Category: Research Source Type: clinical trials